Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Universiteit Maastricht

Home Clinical Trial Sponsors and OrganizationsUniversiteit Maastricht

Universiteit Maastricht

Unknown Belgian address, Unknown, Belgium

Also known as:

niversiteit maastricht

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

747

69 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

18

2.4%

Phase 4

15

2.0%

Phase 3

9

1.2%

Phase 1

2

0.3%

Trial Status Distribution

Active, not recruiting

2

0.3%

Completed

467

62.5%

Not yet recruiting

67

9.0%

Recruiting

184

24.6%

Suspended

1

0.1%

Withdrawn

26

3.5%

Clinical Trials

Trials sponsored by this organization (747)

Microdosing for ADHD and emotion regulation

Jun 2026120 participants

A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous infusion of CP-506, a tumor agnostic Hypoxia Activated Prodrug in patients with HRD/FAD solid tumors or tumor types with high incidence of HRD/FAD in monotherapy or in combination with carboplatin or patients with solid tumor and oligoprogressive disease receiving immune checkpoint inhibitors (ICI): a phase I-IIa clinical trial.

Active, not recruiting

May 202484 participants

Het effect van psilocybine op pijn bij fibromyalgiepatiënten: een multicenter trial

May 202435 participants

an fMRI study on the effects of NicVAX and placebo on Central Nervous System activation and behaviour following a nicotine challenge - NicVAX fMRI study

Active, not recruiting

Mar 201048 participants

Effects of thyroid hormone treatment on mitochondrial function, ectopic fat accumulation, insulin sensitivity and brown adipose tissue in type 2 diabetes mellitus

33 participants

Dietary protein requirements and caloric over-consumption on unbalanced diets

90 participants

To examine the effect of dietary supplementation with fish oils and complex lipids on mitochondrial, physical, and cognitive function, in elderly humans.

108 participants

Blood glucose homeostasis in type 2 diabetes: the effects of sacharose

45 participants

Page 1 of 94

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials747
Approvals
News

Back to Organizations